Results 11 to 20 of about 277,495 (235)

Global challenges of implementing human papillomavirus vaccines [PDF]

open access: yesInternational Journal for Equity in Health, 2011
Human Papillomavirus vaccines are widely hailed as a sweeping pharmaceutical innovation for the universal benefit of all women. The implementation of the vaccines, however, is far from universal or equitable.
Mishra Amrita, Graham Janice E
doaj   +5 more sources

Impact and Cost-Effectiveness of Alternative Human Papillomavirus Vaccines for Preadolescent Girls in Mozambique: A Modelling Study. [PDF]

open access: yesVaccines (Basel), 2023
Mozambique has one of the highest rates of cervical cancer in the world. Human papillomavirus (HPV) vaccination was introduced in 2021. This study evaluated the health and economic impact of the current HPV vaccine (GARDASIL® hereafter referred to as ...
Guimarães EL   +13 more
europepmc   +2 more sources

Prices of paediatric vaccines in European vaccination programmes

open access: yesVaccine: X, 2023
Objective: To compare the vaccine prices per vaccinated child under 18 and vaccine funding and procurement systems in the national vaccination programmes (NVPs) in Europe.
Heini Salo   +6 more
doaj   +1 more source

Stress keratin 17 enhances papillomavirus infection-induced disease by downregulating T cell recruitment.

open access: yesPLoS Pathogens, 2020
High-risk human papillomaviruses (HPVs) cause 5% of human cancers. Despite the availability of HPV vaccines, there remains a strong urgency to find ways to treat persistent HPV infections, as current HPV vaccines are not therapeutic for individuals ...
Wei Wang   +9 more
doaj   +1 more source

Prophylactic HPV vaccines [PDF]

open access: yesArchive of Oncology, 2009
Human papillomavirus (HPV) is one of the most common sexually transmitted diseases worldwide. Cervical and other anogenital cancers, cervical and anal intraepithelial neoplasia, genital warts, and recurrent respiratory papillomatosis are HPV associated ...
Mandić Aljoša
doaj   +1 more source

Novel Antigenic Targets of HPV Therapeutic Vaccines

open access: yesVaccines, 2021
Human papillomavirus (HPV) infection is the cause of the majority of cervical cancers and head and neck cancers worldwide. Although prophylactic vaccines and cervical cancer screening programs have shown efficacy in preventing HPV-associated cervical ...
Ditte Rahbæk Boilesen   +2 more
doaj   +1 more source

Life cycle heterogeneity in animal models of human papillomavirus-associated disease [PDF]

open access: yes, 2002
Animal papillomaviruses are widely used as models to study papillomavirus infection in humans despite differences in genome organization and tissue tropism. Here, we have investigated the extent to which animal models of papillomavirus infection resemble
Peh, W.L.   +21 more
core   +1 more source

Detection and genotyping of human Papillomavirus in urine samples from unvaccinated male and female adolescents in Italy [PDF]

open access: yes, 2013
The introduction of vaccination against Human Papillomavirus (HPV) in adolescent girls in 2006 has focused virological surveillance on this age group. As few studies have evaluated HPV infections in young populations, further data are needed in order to ...
Zotti, CM   +93 more
core   +2 more sources

Prevention of Human Papillomavirus Infection. Beyond Cervical Cancer: A Brief Review

open access: yesActa Médica Portuguesa, 2020
Introduction: Human papillomavirus is responsible for almost all cases of cervical cancer, an important portion of anogenital and oropharyngeal invasive and preinvasive lesions, as well as genital warts (condyloma acuminatum) and recurrent respiratory ...
Rita Medeiros   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy